跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,163 条关于
“[64Cu]Cu-AKY-1189”
全部
2,163
临床试验
1,203
药物
755
机构
19
资讯
186
去年
FDA Clears Phase 1b Trial for Novel Nectin-4 Targeted Radiopharmaceutical AKY-1189 Across Multiple Cancer Types
去年
Novel Mini-Protein AKY-1189 Shows Promise in Targeted Radiation Delivery for Multiple Cancer Types
去年
Aktis Oncology's First-in-Class Nectin-4 Radiopharmaceutical AKY-1189 Shows Promising Tumor Uptake Across Multiple Cancer Types
去年
Clarity Pharmaceuticals and SpectronRx Partner for Phase III Trial Manufacturing of Cu-64 SAR-bisPSMA
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA Gain FDA Fast Track Designations for Prostate Cancer
2年前
Clarity's 64Cu-SAR-bisPSMA Shows Promise in Detecting Prostate Cancer Recurrence in COBRA Trial
4个月前
C-Ray Therapeutics Secures FDA Approval for Copper-64 Drug Master File, Advancing Next-Generation PET Diagnostics
去年
Clarity Pharmaceuticals' 64Cu-SAR-bisPSMA Evaluated in Head-to-Head Prostate Cancer Imaging Trial
去年
uPAR-PET/CT Shows Promise in Primary Breast Cancer Detection, Falls Short in Axillary Staging
去年
Clarity Pharmaceuticals' 64Cu-SARTATE Shows Superior Lesion Detection in Phase II DISCO Trial for Neuroendocrine Tumors
第 1 页,共 19 页
上一页
下一页